title: Comparison of silver sulphadiazine 1 per cent, silver sulphadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent and mafenide acetate 8.5 per cent for topical antibacterial effect in infected full skin thickness rat burn wounds.
abstract: Silver sulphadiazine 1 per cent (SS), silver sulphadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent (SS + CD 0.2 per cent) and mafenide acetate 8.5 per cent (MA) were compared to assess the antibacterial effect of once daily application on experimental rat 20 per cent full skin thickness burn wounds seeded 24 h earlier with 10(8) microorganisms originally isolated from infected wounds of burned patients. Separate series evaluated Staph. aureus, Enterococcus faecalis, Enterobacter cloacae and Ps. aeruginosa. The mean concentration of all four organisms recovered after 1 week from full thickness biopsies of eschar and from separate biopsies of subjacent muscle was less in MA and SS + CD 0.2 per cent treated animals compared with those treated with SS alone. The mean concentration in muscle and eschar following treatment with MA was less for wounds seeded with Staph. aureus and Ps. aeruginosa than with SS + CD 0.2 per cent treatment, while the mean concentration in eschar application of SS + CD 0.2 per cent was less than with MA for E. faecalis seeded wounds.
authors.affiliation: Division of Plastic Surgery, University of British Columbia, Vancouver, Canada.
authors.forename: J H
authors.initials: JH
authors.lastname: Gray
authors.forename: D A
authors.initials: DA
authors.lastname: Henry
authors.forename: M
authors.initials: M
authors.lastname: Forbes
authors.forename: E
authors.initials: E
authors.lastname: Germann
authors.forename: F J
authors.initials: FJ
authors.lastname: Roberts
authors.forename: C F
authors.initials: CF
authors.lastname: Snelling
mesh_terms: D000287:Administration, Topical; D000818:Animals; D001424:Bacterial Infections / Q000517:prevention & control*; D002056:Burns / Q000188:drug therapy* / Q000382:microbiology; D002710:Chlorhexidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D008272:Mafenide / Q000008:administration & dosage / Q000627:therapeutic use*; D011897:Random Allocation; D051381:Rats; D011919:Rats, Inbred Strains; D012837:Silver Sulfadiazine / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D008272:Mafenide; C010882:chlorhexidine gluconate; D002710:Chlorhexidine; D012837:Silver Sulfadiazine